Form 4: Avid Bioservices COO Richard Richieri Reports Stock Transactions

Avid Bioservices' Chief Operations Officer, Richard Richieri, reported the acquisition and disposal of company stock and restricted stock units, including sales to cover tax obligations.

Summary

• Richard Richieri, Chief Operations Officer of Avid Bioservices, Inc., filed a Form 4 detailing changes in his beneficial ownership of company stock.
• The transactions include the acquisition of 5,507 shares of common stock and 464 shares held indirectly by his spouse on January 9, 2025, through the vesting of restricted stock units.
• On January 10, 2025, Mr. Richieri sold 2,283 shares at $12.37 per share and his spouse sold 200 shares at the same price to cover tax obligations related to the vesting of restricted stock units.
• The report also details the disposal of various restricted stock units granted on July 9th of 2021, 2022, 2023 and 2024, which vest quarterly over four years.
• Following these transactions, Mr. Richieri directly owns 49,535 shares and indirectly owns 8,785 shares through his spouse.

Sentiment

Score: 6

Explanation: The document reflects routine insider transactions related to stock-based compensation. While the sales could be perceived negatively, they are explicitly for tax obligations and not necessarily indicative of a negative outlook. Therefore, the sentiment is neutral to slightly positive.

Positives

• The vesting of restricted stock units indicates that Mr. Richieri is meeting the conditions of his employment agreement.
• The sales were explicitly for tax obligations, not necessarily a negative sentiment on the company's future.

Negatives

• The sale of shares, even for tax purposes, could be perceived negatively by some investors as a reduction in insider ownership.

Risks

• While the sales were for tax obligations, continued sales by insiders could put downward pressure on the stock price.
• The vesting schedule of the restricted stock units could lead to further sales in the future.

Future Outlook

The document does not contain any forward-looking statements or guidance.

Industry Context

This is a routine filing for a company with stock-based compensation plans. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• The vesting schedule of restricted stock units over four years with quarterly vesting is a common practice in the biotechnology and pharmaceutical industries, similar to companies like Catalent and Lonza.
• The sale of shares to cover tax obligations is also a standard practice among executives in publicly traded companies, and is not unique to Avid Bioservices.

Stakeholder Impact

• The transactions may have a minor impact on shareholders, as the sale of shares could slightly dilute the stock.
• The vesting of restricted stock units is a positive for the executive, aligning their interests with the company's performance.

Key Dates

Keywords

Avid Bioservices, Richard Richieri, insider trading, Form 4, stock transactions, restricted stock units, CDMO, share sales, beneficial ownership